This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.

People who survive serious COVID-19 have long-lasting immune responses against SARS-COV-2, according to a new study led by Harvard Medical School researchers at Massachusetts General Hospital.
— Read on hms.harvard.edu/news/lasting-defense